Results 11 to 20 of about 112,020 (111)
Vulvovaginal atrophy: modern approaches to diagnostics and management [PDF]
Zaporožskij Medicinskij ŽurnalThe aim of the review is to analyze the latest data on the current state of diagnosis and management of a common benign vulvar and vaginal disease in postmenopausal women – atrophic vulvovaginitis.
V. H. Siusiuka +4 more
doaj +2 more sources
Lubricants application in vulvovaginal atrophy [PDF]
РМЖ. Мать и дитя, 2018 Lubricants application in vulvovaginal atrophy Yu.E. Dobrokhotova, S.A. Khlynova Pirogov Russian National Research Medical University, Moscow, Russian Federation Interim periods as well as the postmenopausal period are extremely important in ...
Yu.E. Dobrokhotova, S.A. Khlynova
doaj +1 more source
Clinical and morphological aspects of vulvovaginal atrophy
Медицинский совет, 2014 Vulvovaginal atrophy is one of the most annoying and undesirable manifestations of estrogen deficiency. 77% of women feel uncomfortable to discuss the symptoms with their doctor.
I. A. Apolikhina, E. A. Gorbunova
doaj +2 more sources
Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy [PDF]
International Journal of Women's Health, 2013 Sharon J Parish,1 Rossella E Nappi,2 Michael L Krychman,3 Susan Kellogg-Spadt,4 James A Simon,5 Jeffrey A Goldstein,6 Sheryl A Kingsberg7 1Albert Einstein College of Medicine, Bronx, NY, USA; 2Department of Obstetrics and Gynecology, IRCCS Policlinico ...
Parish SJ +6 more
doaj +2 more sources
Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
Акушерство, гинекология и репродукция, 2019 Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for more than a third of their life time. According to the recent document on the stages of aging of the female reproductive system (the STRAW+10 working ...
A. D. Makatsariya +3 more
doaj +2 more sources
Vulvovaginal Atrophy Following Treatment for Oncogynecologic Pathologies: Etiology, Epidemiology, Diagnosis, and Treatment Options [PDF]
MedicinaVulvovaginal atrophy, characterized by the thinning of vaginal mucosa typically resulting from reduced estrogen levels, is frequently exacerbated by oncogynecologic treatments such as chemotherapy, hormonal therapy, radiotherapy, or surgery.
Ramunė Narutytė +2 more
doaj +2 more sources
Update on alternative therapies for vulvovaginal atrophy
Patient Preference and Adherence, 2011 Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Although systemic absorption of estrogen with local treatment for vulvovaginal atrophy (VVA) is most likely to be negligible, it is ...
Chollet J
doaj +2 more sources
MedicinaWe write with concerns regarding the recent publication of “Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy” [...]
Catherine Broomfield +2 more
doaj +2 more sources
International Journal of Women's Health, 2009 SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj +1 more source
Topical Spermidine Hyaluronate (Spd-HA) in Vulvovaginal Atrophy: A Preliminary Study
MedicinaBackground and Objectives: Genitourinary syndrome of menopause (GSM), previously termed vulvovaginal atrophy (VVA), is a prevalent hypoestrogenic condition characterized by genital, sexual, and urinary symptoms. Although hormonal therapies are effective,
Irene Porcari +9 more
doaj +2 more sources